Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL18422877 | 0.97 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL13547835 | 0.92 | ALDH1A1 (0.57) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL6851329 | 0.90 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL6847397 | 0.90 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL6850263 | 0.90 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL20024746 | 0.88 | PPARA (0.51) | MAPTLMNASMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL10030181 | 0.87 | L3MBTL1 (0.55) | ALDH1A1MAPTLMNASMN1; SMN2KMT2A | |
| SCHEMBL5549982 | 0.85 | CHRNB2 (0.51) | ALDH1A1MAPTLMNAKMT2AL3MBTL1 | |
| SCHEMBL11685734 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL6552735 | 0.84 | POLB (0.56) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180094155-A1 | INKJET INK AND COLORING COMPOSITION | RICOH COMPANY, LTD. (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20140364519-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2014-12-11 | — | — | US | disclosed |
| EP-0464904-A2 | An optical article exhibiting a high level of second order polarization susceptibility | EASTMAN KODAK COMPANY (US) | 1992-01-08 | — | — | EP | disclosed |
| US-5029979-A | Optical article exhibiting a high level of second order polarization susceptibility | EASTMAN KODAK COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364519-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SPR, SELPLG, SIGLEC7 | ALDH1A1 1262/4885MAPT 4419/4885HPGD 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.